Skip to Main content Skip to Navigation
Journal articles

Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents

Abstract : BACKGROUND: The widespread use of praziquantel for the treatment of schistosomiasis has led to concerns over the potential development of drug resistance. Therefore, the discovery of novel antischistosomal agents is imperative. In this study, a series of praziquantel and endoperoxide conjugates were synthesized and evaluated as potential antischistosomal agents. RESULTS: Some compounds exhibited high efficacy against both adult and juvenile Schistosoma, in in vitro studies. Structure-activity relationship (SAR) analysis revealed that compounds with amide bond linker and cyclopentyl adjacent to the 1,2,4,5-tetraxane pharmacophore displayed the highest efficacy. Overall, compounds showed consistent activity against Schistosoma japonicum and Schistosoma mansoni. In vivo study resulted in moderate but statistically significant activity. CONCLUSION: Important preliminary results were obtained from thorough activity evaluation of praziquantel-endoperoxide conjugates. Further pharmacokinetic property investigation is necessary to improve in vivo efficacy.
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01161571
Contributor : Anne Modat <>
Submitted on : Monday, June 8, 2015 - 4:38:58 PM
Last modification on : Thursday, October 24, 2019 - 3:02:03 PM

Links full text

Identifiers

Collections

Citation

J. J. Yang, Jérôme Boissier, Jie Chen, H. Yao, S. Yang, et al.. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents. Future Medicinal Chemistry, Future Science, 2015, 7 (6), pp.713-725. ⟨10.4155/fmc.15.20⟩. ⟨hal-01161571⟩

Share

Metrics

Record views

206